Johnson & Johnson Change company Symbol lookup Go Health Care : Pharmaceuticals | Large Cap ValueCompany profile Postmarket Last Trade $158.60 Change Since Close 0.52 (0.33%) Bid -- Ask -- B/A Size -- December 01, 2021 7:59pm ET Market Hours Closing Price $158.08 Day's Change 2.15 (1.38%) Bid -- Ask -- B/A Size -- Day's High 160.08 Day's Low 156.25 Volume(Heavy Day) 9,836,412 December 01, 2021 7:00pm ET Historical quotes & splits SummaryNewsChartsEarningsFundamentalsValuationCalendarPeer ComparisonSEC Filings JNJ's position in the Pharmaceuticals industry Stock Price vs. Peers1d2d5d1mo3mo6mo1yr3yr Industry Peers JNJ MRK RETA PBH ZGNX Summary Company Profile Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments... Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through... Go to MRK summary Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on identifying, developing, and commercializing therapies. The Company is also focused on providing... Go to RETA summary Prestige Consumer Healthcare Inc. is engaged in the marketing, sales and distribution of over the counter (OTC) healthcare products to mass merchandisers, drug, food, dollar, convenience and club... Go to PBH summary Zogenix, Inc. is a global biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for rare diseases. It is primarily focused on developing and... Go to ZGNX summary 52-Week Change 7.21% -8.72% -40.03% 58.77% -43.59% Market Cap $410.5B $189.2B $3.1B $2.8B $629.9M Beta 0.7 0.5 1.5 0.7 1.2 Dividend Yield 2.72% 3.47% -- -- -- P/E (TTM, GAAP) 23.31x 29.59x -- 15.76x -- Data as of November 30, 2021 November 30, 2021 November 30, 2021 November 30, 2021 November 30, 2021 Fundamentals Total Revenue (TTM) $91.4B $47.7B $13.7M $1.0B $63.6M Profit Margin 19.55% 13.51% -2,021.22% 17.56% -381.69% Earnings Growth (5 year, GAAP) -0.30% 12.21% -- 11.60% -- Revenue Growth (TTM) 13.10% 0.74% 61.78% 6.50% 796.83% Data as of October 3, 2021 September 30, 2021 September 30, 2021 September 30, 2021 September 30, 2021 Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies. Market data and information provided by Morningstar. Copyright © 2021. All rights reserved. Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world. Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters. 3rd Party Research Disclosure